I get it, but the "die is cast" and NP will be the
Post# of 148337
Never been a "basher", nor supportive of those that do, not a "pumper" or "fan boy" of NP, just "sold out and all in" on the science. Our CEO has both his strengths and his weaknesses. He has done wonderfully in some areas and fell short in others. IMHO, we still very much need his "Energizer Bunny" efforts and his undeniable passion about this molecule. Personally, I would love to see him start out each conference call with no more than a 3-5 minute "overview" to us and then handoff to Dr. Kelly, who would make his opening statement and then area by area call on and ask Dr. Recknor, about his doings and so on and so on. Dr. Kelly could summarize, then hand back to NP to make his closing, before Dr Kelly moderates Q&A the same way by asking each management team member to field the questions that are in their wheelhouse.
Some will agree with my suggestions above, many may reject them, but I am sincere. Some will still insist our only path forward is replacing NP and doing it NOW! If we get to 2nd qtr 2022 and no approvals, no BTD's, no partnerships that make sense, I would be on the other side of the fence IF it seemed inevitable.
That said, I have seen all too close and up front, how any organization can be disrupted and sometimes, outright destroyed by a seemingly necessary, but ill timed change in management. It has been stated and restated, so many times, "timing is critical". Change your pitcher one pitch after he gives up the go ahead run and you may lose the game, pull him too early and the bull pen isn't ready and will likely fail massively.
I believe we will see positive milestones hit over the next 3-4 months, I do not believe the doubters will sway enough of us to destroy our company to assuage their misplaced anger due to an outsized investment they made or their unmet expectations that a pre revenue, start up bio tech would be run like a buttoned down Fortune 500 company.